In the health care system, cost-effectiveness analysis is the most influential tools needed to reduce the burden of any diseases (Watkins, Mvundura, Nordet, & Mayosi, 2015). Economical costs are mostly impacted when the burden of a disease remains ultimately high with little budget to intervene from the public sectors (Watkins et al., 2015). Cardiovascular diseases (CVD), which involves heart or blood vessels is known to cause coronary heart disease, stroke, and congestive heart failures (Bloom, et al., 2011). The CVD components make up 82% of the mortality cases (Bloom, et al., 2011). The impact of CVD associated death takes place between the ages of 35-64 that of the working labor force age resulting in economical loss of wages (Bloom,
